IL-6, rKT, QUIN, and KYN measured in the 2nd trimester have strong evidence (>95% chance) of being positively associated with both depression severity (EPDS) and risk of significant depressive symptoms (EPDS ≥ 13) in the 3rd trimester. The gene discussed is IL6; the disease is depressive disorder.